A phase 1 expansion cohort study evaluating the safety and efficacy of the CHK1 inhibitor LY2880070 with low-dose gemcitabine in metastatic pancreatic adenocarcinomaBrandon M. Huffman,Hanrong Feng,Kalindi Parmar,Junning Wang,Kevin Kapner,Bose Kochupurakkal, David Martignetti,Thomas Abrams,Leah Biller,Marios Giannakis,Kimmie Ng,Anuj Patel,Kimberly Perez,Harshabad Singh,Douglas Rubinson,Benjamin Schlechter,Elizabeth Andrews, Alison Hannigan, Stanley Dunwell, Zoe Getchell,Srivatsan Raghavan,Brian Wolpin, Alan D'Andrea,Andrew Aguirre,Geoffrey Shapiro,James ClearyCANCER RESEARCH（2024）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
